Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: Incidence, risk factors, and prevention

Journal of Infectious Diseases

Volumn 181, Issue 4, 2000, Pages 1428-1434

  Woods, Christopher W ^a,b,e   McRill, Cheryl ^c   Plikaytis, Brian D ^b   Rosenstein, Nancy E ^b   Mosley, David ^c   Boyd, Denise ^c   England, Bob ^c   Perkins, Bradley A ^b   Ampel, Neil M ^d   Hajjeh, Rana A ^b  

^a Epidemiology and Analysis Program Office   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANDIDIASIS; COCCIDIOIDOMYCOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; THRUSH;

EID: 0034105276     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315401     Document Type: Article

References (33)

1. 1. Galgiani J. Coccidioidomycosis. West J Med 1993; 159:153-71.
2. 2. Pappagianis D. Epidemiology of coccidioidomycosis. In: McGinnis M, ed. Current topics in medical mycology. Vol 2. New York: Springer Verlag, 1978:199-238.
3. 3. Smith CE, Beard RR, Whiting EG, Rosenberger HG. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health 1941; 36:1394-402.
4. 4. Einstein HE, Johnson RH. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis 1993; 16:349-56.
5. 5. Drutz DJ, Huppert M. Coccidioidomycosis: factors affecting the host parasite interaction. J Infect Dis 1983; 147:372-90.
6. 6. Smale LE, Waechter KG. Dissemination of coccidioidomycosis in pregnancy. Am J Obstet Gynecol 1970; 107:356-61.
7. 7. Kovacs JA, Forthal DN, Kovacs JA, Overturf GD. Disseminated coccidioidomycosis in a patient with acquired immune deficiency syndrome. West J Med 1984; 140:447-9.
8. 8. Abrams DI, Robia M, Blumenfeld W, Simonson J, Cohen M, Hadley WK. Disseminated coccidioidomycosis in AIDS [letter]. N Engl J Med 1984; 310:986-7.
9. 9. Bronnimann DA, Adam RD, Galgiani JN. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106:372-9.
10. 10. Centers for Disease Control and Prevention. Coccidioidomycosis Arizona, 1990-1995. MMWR Morb Mortal Wkly Rep 1996; 45:1069-73.
11. 11. Ampel NM, Mosely DM, England R, Komatsu K, Hajjeh R. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis 1998; 27:1528-30.
12. 12. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993; 94:235-8.
13. 13. Jones JL, Fleming PL, Ciesielski CA, Hu DJ, Kaplan JE, Ward JW. Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis 1995; 171:961-6.
14. 14. Hajjeh RA, Ampel NM. Histoplasmosis and coccidioidomycosis in persons with HIV infection. Infect Dis Clin Pract 1996; 5:126-9.
15. 15. Nightingale SD, Cal SX, Peterson DM, et al. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS 1992; 6:191-4.
16. 16. Powderly WG, Finkelstein DM, Fineberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332:700-5.
17. 17. McKinsey DS, Wheat LJ, Cloud GA, et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. Clin Infect Dis 1999; 28:1049-56.
18. 18. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997; 46:1-55.
19. 19. Dean AF, Dean JA, Burton AH, Dicker RC. Epi Info, version 6: a word processing, database, and statistics program for epidemiology on micro-computers. Atlanta: Centers for Disease Control and Prevention, 1995.
20. 20. SAS language: version 6. Cary, NC: SAS Institute, 1990.
21. 21. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41:1-19.
22. 22. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection: a review of 77 patients. Medicine 1990; 69:384-91.
23. 23. Papagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev 1990; 3:247-68.
24. 24. Antoniskis D, Larsen RA, Bisker A, Rarick MU, Leedom JM. Seronegative disseminated coccidioidomycosis in patients with HIV infection. AIDS 1990; 4:691-3.
25. 25. Centers for Disease Control and Prevention. Surveillance for AIDS-defining opportunistic infections, 1992-1997. MMWR Morb Mortal Wkly Rep 1999; 48:1-22.
26. 26. Kaplan JE, Hanson DL, Navin TR, Jones JL. Risk factors for primary Pneumocystis carinii pneumonia in HIV-infected adolescents and adults: reassessment of indications for chemoprophylaxis. J Infect Dis 1998; 178: 1126-32.
27. 27. Phair J, Munoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with HIV-1. N Engl J Med 1990; 322:161-5.
28. 28. Tascini C, Baldelli F, Monari C, et al. Inhibition of fungicidal activity of polymorphonuclear leukocytes from HIV-infected patients by interleukin (IL)-4 and IL-10. AIDS 1996; 10:477-83.
29. 29. Rosenstein NE, Werner SB, Kao A, et al. Coccidioidomycosis risk factors for severe pulmonary and disseminated disease [abstract 637]. In: Proceedings of the 35th annual meeting of the Infectious Diseases Society of America (San Francisco). Washington, DC: Infectious Diseases Society of America, 1997.
30. 30. Centers for Disease Control and Prevention. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1997; 46:1-46.
31. 31. Schneider E, Hajjeh RA. Spiegel RA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, Earthquake. JAMA 1997; 277:904-8.
32. 32. Galgiani JN, Cloud GA, Catanzaro A, et al. Fluconazole vs. itraconazole for coccidioidomycosis: randomized, multicenter double-blinded trial in nonmeningeal progressive infections [abstract 100]. In: Proceedings of the 36th annual meeting of the Infectious Diseases Society of America (Denver). Washington, DC: Infectious Diseases Society of America, 1998.
33. The Journal of Infectious Diseases 2000; 181:1435-40